Physician profile
Jennifer E Bernstein
NPI 1407296171
$9,904.98
in general payments reported to CMS, 2019-2025
46 companies · $1,775 in 2025
The $1,775 reported for 2025 was more than what 93% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,807 · 2020: $397 · 2021: $923 · 2022: $1,743 · 2023: $1,821 · 2024: $1,439 · 2025: $1,775.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,747 · Travel and Lodging: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,747.43 |
| Travel and Lodging | $288.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,245.06 | 2019-2025 | Grafix Pl, Stravix, Oasis |
| Melinta Therapeutics, LLC | $1,280.12 | 2019-2025 | Orbactiv, Kimyrsa, Rezzayo |
| Kerecis Limited | $1,062.60 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Organogenesis INC. | $983.45 | 2021-2024 | Puraply, Puraply Franchise |
| Stryker Corporation | $964.26 | 2019-2025 | Augment Injectable, Allograft Bio-Implants, Limflow System |
| Acera Surgical, INC. | $306.00 | 2019-2023 | Restrata Wound Matrix |
| Horizon Therapeutics Plc | $294.32 | 2019-2023 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $281.48 | 2019-2025 | Nuzyra |
| Koya Medical, INC. | $187.48 | 2024 | Dayspring, Koya Medical |
| Medline Industries LP | $182.03 | 2019-2025 | |
| Alafair Biosciences, INC. | $177.25 | 2024 | Versawrap |
| Bioventus LLC | $176.24 | 2020-2025 | Exogen Ultrasound Bone Healing System, Xcell |
| Orthofix Medical, INC. | $167.62 | 2020-2025 | Physio-Stim |
| Abbott Laboratories | $144.45 | 2019-2023 | Armada |
| Osiris Therapeutics INC. | $134.13 | 2019 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $123.63 | 2025 | Exparel |
| Novastep INC. | $118.05 | 2021 | |
| Sebela Pharmaceuticals INC. | $110.25 | 2019-2023 | Naftin, Pramosone |
| Vaporox, INC. | $93.16 | 2023 | Vht-200 Wound Treatment System |
| Amgen INC. | $78.66 | 2024 | Krystexxa |
| Polynovo North America LLC | $73.30 | 2022-2025 | Novosorb Btm |
| Solventum Corporation | $64.27 | 2024-2025 | V.A.C. Veraflo Cleanse Choice, V.A.C. Veraflo, Activ.A.C. |
| Kci USA, INC. | $64.00 | 2020-2023 | Activ.A.C. |
| Urgo Medical North America, LLC | $51.25 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Nabriva Therapeutics, Plc | $44.93 | 2022 | |
| Treace Medical Concepts, INC. | $43.22 | 2023-2025 | |
| Mimedx Group, INC. | $40.23 | 2024-2025 | |
| Depuy Synthes Sales INC. | $34.44 | 2023 | Motoband |
| Hartmann USA, INC. | $33.43 | 2022 | |
| Sanara Medtech INC. | $31.50 | 2021 | |
| Ani Pharmaceuticals, INC. | $29.35 | 2024 | Purified Cortrophin Gel |
| Paragon 28, INC. | $27.45 | 2025 | Portfolio |
| Reprise Biomedical, INC. | $27.06 | 2023 | Miro3d |
| Bone Support INC. | $25.50 | 2024 | Cerament G, Ceramentbone Void Filler |
| Averitas Pharma INC. | $22.36 | 2023 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $21.54 | 2025 | |
| Zimmer Biomet Holdings, INC. | $19.52 | 2021 | |
| Acumed LLC | $18.51 | 2025 | Acumed |
| Dynasplint Systems INC. | $17.04 | 2023 | Dynasplint |
| Omeza LLC | $16.23 | 2024 | |
| Celularity INC. | $16.00 | 2019 | |
| Merck Sharp & Dohme LLC | $15.73 | 2019 | |
| Medtronic Vascular, INC. | $15.48 | 2019 | |
| Curonix LLC | $15.11 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Next Science LLC | $14.80 | 2023 | Surgx, Xperience, Blastx |
| Grt US Holding, INC. | $12.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.